Literature DB >> 8867420

The Indiana Prenatal Substance Use Prevention Program: its impact on smoking cessation among high-risk pregnant women.

C S Waller1, T W Zollinger, R W Saywell, K D Kubisty.   

Abstract

The Indiana Prenatal Substance Use Prevention Program (PSUPP) was established in 1988 to help pregnant women quit cigarette smoking as well as alcohol and drugs. PSUPP directors implement the Screen, Intervene and Follow-up (SIF) model to assess substance use and provide services to help clients stop smoking. During fiscal year 1995, almost 25,000 individuals were impacted directly or indirectly by the PSUPP. Of these, 1,334 pregnant women were screened for substance use by PSUPP. Of the 987 women identified with a known substance use risk factor, 42.4% (418) were high-risk smokers (more than five cigarettes per day) and 9.9% (98) were medium-risk smokers (smoking between one and four cigarettes per day). PSUPP directors counseled their high/medium risk smokers an average of four times during their pregnancy. The PSUPP appears to be effective in getting high-risk smokers to change their smoking behavior during their pregnancy. Approximately one-half (49.9%) of the 516 high- or medium-risk smokers decreased or quit smoking while participating in the PSUPP. When surveyed, about 80% of the PSUPP participants stated that the knowledge they gained through PSUPP relative to tobacco use was "very helpful." Only two-thirds of the PSUPP clients responded that they "strongly agreed" with the statement that tobacco use causes babies to have a lower birth weight. While pregnancy may provide the "teachable moment" for women who smoke, more attention needs to be placed on making women more aware of the risks involved with smoking during pregnancy.

Entities:  

Mesh:

Year:  1996        PMID: 8867420

Source DB:  PubMed          Journal:  Indiana Med        ISSN: 0746-8288


  4 in total

1.  A prenatal intervention study to improve timeliness of immunization initiation in Latino infants.

Authors:  María Luisa Zúñiga de Nuncio; Philip R Nader; Mark H Sawyer; Michelle De Guire; Radmila Prislin; John P Elder
Journal:  J Community Health       Date:  2003-04

2.  A pilot multisite study of patient navigation for pregnant women with opioid use disorder.

Authors:  Gerald Cochran; Marcela C Smid; Elizabeth E Krans; M Aryana Bryan; Adam J Gordon; Brad Lundahl; John Silipigni; Benjamin Haaland; Ralph Tarter
Journal:  Contemp Clin Trials       Date:  2019-11-12       Impact factor: 2.226

3.  Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.

Authors:  Margaret S Chisolm; Michelle Tuten; Emily C Brigham; Eric C Strain; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Sep-Oct

Review 4.  Smoking cessation interventions for pregnant women attending treatment for substance use disorders: A systematic review.

Authors:  Melissa A Jackson; Amanda L Baker; Gillian S Gould; Amanda L Brown; Adrian J Dunlop; Kristen McCarter
Journal:  Addiction       Date:  2021-09-28       Impact factor: 7.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.